Nutrition, inflammation, and cognitive function

Annals of the New York Academy of Sciences

Volumn 1153, Issue , 2009, Pages 164-175

  Wärnberg, Julia ^a,b,c   Gomez Martinez, Sonia ^a   Romeo, Javier ^a   Díaz, Ligia Esperanza ^a   Marcos, Ascensión ^a  

^a INSTITUTE OF FOOD SCIENCE   (Spain)

^b KAROLINSKA INSTITUTE   (Sweden)

^c INSTITUTO DEL FRÍO CSIC   (Spain)

Author keywords

Anti inflammatory diet; Antioxidants; C reactive protein; Cytokines; Dementia; Low grade chronic inflammation; Mediterranean diet; Neurodegenerative disorders; Phytochemicals; Polyunsaturated fatty acids

Indexed keywords

ANTIOXIDANT; C REACTIVE PROTEIN; PLANT MEDICINAL PRODUCT; POLYUNSATURATED FATTY ACID;

ANTIINFLAMMATORY ACTIVITY; BRAIN DEVELOPMENT; BRAIN FUNCTION; COGNITION; CONFERENCE PAPER; CYTOKINE PRODUCTION; DEGENERATIVE DISEASE; DEMENTIA; DIABETES MELLITUS; DIETARY INTAKE; HUMAN; INFLAMMATION; INFLAMMATORY CELL; LIFESTYLE; MEDITERRANEAN DIET; MENTAL DISEASE; METABOLIC SYNDROME X; NUTRITION; OBESITY;

EID: 60349132062     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2008.03985.x     Document Type: Conference Paper

References (126)

1. Hansson, G.K. 2001. Regulation of immune mechanisms in atherosclerosis. Ann. N. Y. Acad. Sci. 947 : 157 165 discussion 165-156.
2. Libby, P. 2006. Inflammation and cardiovascular disease mechanisms. Am. J. Clin. Nutr. 83 : 456S 460S.
3. Hansson, G.K. 2005. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352 : 1685 1695.
4. Hotamisligil, G.S. 2006. Inflammation and metabolic disorders. Nature 444 : 860 867.
5. Vogt, B. et al. 2007. CRP and the disposal of dying cells: consequences for systemic lupus erythematosus and rheumatoid arthritis. Autoimmunity 40 : 295 298.
6. de Visser, K.E., A. Eichten & L.M. Coussens. 2006. Paradoxical roles of the immune system during cancer development. Nat. Rev. Cancer 6 : 24 37.
7. Teunissen, C.E. et al. 2003. Inflammation markers in relation to cognition in a healthy aging population. J. Neuroimmunol. 134 : 142 150.
8. Britschgi, M. & T. Wyss-Coray. 2007. Immune cells may fend off Alzheimer disease. Nat. Med. 13 : 408 409.
9. Kuo, H.K. et al. 2005. Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Lancet Neurol. 4 : 371 380.
10. Gunstad, J. et al. 2006. C-reactive protein, but not homocysteine, is related to cognitive dysfunction in older adults with cardiovascular disease. J. Clin. Neurosci. 13 : 540 546.
11. Dimopoulos, N. et al. 2006. Indices of low-grade chronic inflammation correlate with early cognitive deterioration in an elderly Greek population. Neurosci. Lett. 398 : 118 123.
12. Ravaglia, G. et al. 2005. Serum C-reactive protein and cognitive function in healthy elderly Italian community dwellers. J. Gerontol. A Biol. Sci. Med. Sci. 60 : 1017 1021.
13. Pearson, T.A. et al. 2003. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 : 499 511.
14. Ridker, P.M. et al. 2003. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107 : 391 397.
15. Ridker, P.M., M.J. Stampfer & N. Rifai. 2001. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 285 : 2481 2485.
16. Pratico, D. & J. Trojanowski. 2000. Inflammatory hypotheses: novel mechanisms of Alzheimer's neurodegeneration and new therapeutic targets? Neurobiol. Aging 21 : 441 445.
17. Din, J.N., D.E. Newby & A.D. Flapan. 2004. Omega 3 fatty acids and cardiovascular disease - fishing for a natural treatment. BMJ 328 : 30 35.
18. Kris-Etherton, P.M. et al. 2003. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 23 : e20 30.
19. Calder, P.C. 2006. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am. J. Clin. Nutr. 83 : S1505 S1519.
20. Abramson, J.L. et al. 2005. Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease. Atherosclerosis 178 : 115 121.
21. Hughes, D.A. 2000. Dietary antioxidants and human immune function. Nutr. Bull. 25 : 35 41.
22. Maron, D.J. 2004. Flavonoids for reduction of atherosclerotic risk. Curr. Atheroscler. Rep. 6 : 73 78.
23. van Herpen-Broekmans, W.M. et al. 2004. Serum carotenoids and vitamins in relation to markers of endothelial function and inflammation. Eur. J. Epidemiol. 19 : 915 921.
24. Brighenti, F. et al. 2005. Total antioxidant capacity of the diet is inversely and independently related to plasma concentration of high-sensitivity C-reactive protein in adult Italian subjects. Br. J. Nutr. 93 : 619 625.
25. Ajani, U.A., E.S. Ford & A.H. Mokdad. 2004. Dietary fiber and C-reactive protein: findings from national health and nutrition examination survey data. J. Nutr. 134 : 1181 1185.
26. Wärnberg, J. et al. 2006. Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: the AVENA Study. Am. J. Clin. Nutr. 84 : 505 512.
27. Wärnberg, J. et al. 2007. Lifestyle-related determinants of inflammation in adolescence. Br. J. Nutr. 98 : S116 120.
28. Bazzano, L.A. et al. 2003. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann. Intern. Med. 138 : 891 897.
29. Wärnberg, J. & A. Marcos. 2008. Low-grade inflammation and the metabolic syndrome in children and adolescents. Curr. Opin. Lipidol. 19 : 11 15.
30. Petersen, A.M. & B.K. Pedersen. 2005. The anti-inflammatory effect of exercise. J. Appl. Physiol. 98 : 1154 1162.
31. Lopez-Garcia, E. et al. 2004. Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am. J. Clin. Nutr. 80 : 1029 1035.
32. Schulze, M.B. et al. 2005. Dietary pattern, inflammation, and incidence of type 2 diabetes in women. Am. J. Clin. Nutr. 82 : 675 684.
33. Giugliano, D., A. Ceriello & K. Esposito. 2006. The effects of diet on inflammation: emphasis on the metabolic syndrome. J. Am. Coll. Cardiol. 48 : 677 685.
34. Trichopoulou, A. et al. 2003. Adherence to a Mediterranean diet and survival in a Greek population. N. Engl. J. Med. 348 : 2599 2608.
35. Trichopoulou, A. et al. 2000. Cancer and Mediterranean dietary traditions. Cancer Epidemiol. Biomarkers Prev. 9 : 869 873.
36. Trichopoulou, A. et al. 2005. Modified Mediterranean diet and survival: EPIC-elderly prospective cohort study. BMJ 330 : 991.
37. Alonso, A. & M.A. Martinez-Gonzalez. 2005. Mediterranean diet, lifestyle factors, and mortality. JAMA 293 : 674.
38. Martinez-Gonzalez, M.A. et al. 2008. Mediterranean Diet Inversely Associated With the Incidence of Metabolic Syndrome: the SUN Prospective Cohort: Response to Giugliano, Ceriello, and Esposito. Diabetes Care 31 : e37.
39. Martinez-Gonzalez, M.A. et al. 2008. Adherence to Mediterranean diet and risk of developing diabetes: prospective cohort study. BMJ 336 : 1348 1351.
40. Salas-Salvado, J. et al. 2008. Components of the Mediterranean-type food pattern and serum inflammatory markers among patients at high risk for cardiovascular disease. Eur. J. Clin. Nutr. 62 : 651 659.
41. Chrysohoou, C. et al. 2004. Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: The ATTICA Study. J. Am. Coll. Cardiol. 44 : 152 158.
42. Esposito, K. et al. 2004. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 292 : 1440 1446.
43. Martinez-Gonzalez, M.A. et al. 2003. What is protective in the Mediterranean diet? Atherosclerosis 166 : 405 407.
44. Bourre, J.M. 2006. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 2: macronutrients. J. Nutr. Health Aging 10 : 386 399.
45. Bourre, J.M. 2006. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients. J. Nutr. Health Aging 10 : 377 385.
46. Bryan, J. et al. 2004. Nutrients for cognitive development in school-aged children. Nutr. Rev. 62 : 295 306.
47. Uauy, R., F. Calderon & P. Mena. 2001. Essential fatty acids in somatic growth and brain development. World Rev. Nutr. Diet. 89 : 134 160.
48. Wainwright, P. 2000. Nutrition and behaviour: the role of n-3 fatty acids in cognitive function. Br. J. Nutr. 83 : 337 339.
49. Birberg-Thornberg, U. et al. 2006. Nutrition and theory of mind - The role of polyunsaturated fatty acids (PUFA) in the development of theory of mind. Prostaglandins Leukot Essent Fatty Acids 75 : 33 41.
50. Eilander, A. et al. 2007. Effects of n-3 long chain polyunsaturated fatty acid supplementation on visual and cognitive development throughout childhood: a review of human studies. Prostaglandins Leukot Essent Fatty Acids 76 : 189 203.
51. Hart, C.L. et al. 2004. Childhood IQ and cardiovascular disease in adulthood: prospective observational study linking the Scottish Mental Survey 1932 and the Midspan studies. Soc. Sci. Med. 59 : 2131 2138.
52. Lucas, S.-M., N.J. Rothwell & R.M. Gibson. 2006. The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 147 : S232 S240.
53. McGeer, P.L., K. Yasojima & E.G. McGeer. 2001. Inflammation in Parkinson's disease. Adv. Neurol. 86 : 83 89.
54. Campbell, A. 2004. Inflammation, neurodegenerative diseases, and environmental exposures. Ann. N. Y. Acad. Sci. 117 132.
55. Duong, T., P.J. Acton & R.A. Johnson. 1998. The in vitro neuronal toxicity of pentraxins associated with Alzheimer's disease brain lesions. Brain Res. 303 312.
56. McGeer, P.L., E.G. McGeer & K. Yasojima. 2000. Alzheimer disease and neuroinflammation. J. Neural. Transm. Suppl. 59 : 53 57.
57. Yasojima, K. et al. 2000. Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease. Brain Res. 887 : 80 89.
58. Duong, T., M. Nikolaeva & P.J. Acton. 1997. C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer's disease. Brain Res. 749 : 152 156.
59. Mast, B.T. 2004. Cerebrovascular disease and late-life depression: a latent-variable analysis of depressive symptoms after stroke. Am. J. Geriatr. Psychiatry 12 : 315 322.
60. Lowery, K. et al. 2002. Cognitive decline in a prospectively studied group of stroke survivors, with a particular emphasis on the >75's. Age Ageing 31 : S24 27.
61. Stephens, S. et al. 2004. Neuropsychological characteristics of mild vascular cognitive impairment and dementia after stroke. Int. J. Geriatr. Psychiatry 19 : 1053 1057.
62. Lindsberg, P.J. & A.J. Grau. 2003. Inflammation and infections as risk factors for ischemic stroke. Stroke 2518 2532.
63. Engelhart, M.J. et al. 2004. Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. Arch. Neurol. 61 : 668 672.
64. Licinio, J. & M.L. Wong. 1999. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol. Psychiatry 4 : 317 327.
65. Wyss-Coray, T. 2006. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat. Med. 12 : 1005 1015.
66. Ahluwalia, N. 2004. Aging, nutrition and immune function. J. Nutr. Health Aging 8 : 2 6.
67. Bruunsgaard, H. et al. 2003. Elevated levels of tumor necrosis factor alpha and mortality in centenarians. Am. J. Med. 115 : 278 283.
68. Pratico, D. 2002. Alzheimer's disease and oxygen radicals: new insights. Biochem. Pharmacol. 63 : 563 567.
69. Pappolla, M.A. et al. 2002. Cholesterol, oxidative stress, and Alzheimer's disease: expanding the horizons of pathogenesis. Free Radic. Biol. Med. 33 : 173 181.
70. Morris, M.C. et al. 2002. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA 287 : 3230 3237.
71. Zandi, P.P. et al. 2004. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. Arch. Neurol. 61 : 82 88.
72. in t' Veld, B.A. et al. 2001. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N. Engl. J. Med. 345 : 1515 1521.
73. Bokov, A., A. Chaudhuri & A. Richardson. 2004. The role of oxidative damage and stress in aging. Mech. Ageing Dev. 125 : 811 826.
74. Galli, R.L. et al. 2002. Fruit polyphenolics and brain aging: nutritional interventions targeting age-related neuronal and behavioral deficits. Ann. N. Y. Acad. Sci. 959 : 128 132.
75. Joseph, J.A., B. Shukitt-Hale & G. Casadesus. 2005. Reversing the deleterious effects of aging on neuronal communication and behavior: beneficial properties of fruit polyphenolic compounds. Am. J. Clin. Nutr. 81 : 313S 316S.
76. Joseph, J.A., B. Shukitt-Hale & F.C. Lau. 2007. Fruit polyphenols and their effects on neuronal signaling and behavior in senescence. Ann. N. Y. Acad. Sci. 1100 : 470 485.
77. Lau, F.C., B. Shukitt-Hale & J.A. Joseph. 2005. The beneficial effects of fruit polyphenols on brain aging. Neurobiol. Aging 26 (Suppl 1 128 132.
78. Liu, R.H. 2003. Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am. J. Clin. Nutr. 78 : S517 520.
79. Ikeda, K., H. Negishi & Y. Yamori. 2003. Antioxidant nutrients and hypoxia/ischemia brain injury in rodents. Toxicology 189 : 55 61.
80. Mancuso, C. et al. 2007. Natural antioxidants in Alzheimer's disease. Expert Opin. Investig. Drugs 16 : 1921 1931.
81. Cole, G.M. et al. 2005. Prevention of Alzheimer's disease: omega-3 fatty acid and phenolic anti-oxidant interventions. Neurobiol. Aging 26 : S133 136.
82. Das, U.N. 2008. Folic acid and polyunsaturated fatty acids improve cognitive function and prevent depression, dementia, and Alzheimer's disease-but how and why? Prostaglandins Leukot Essent Fatty Acids 78 : 11 19.
83. Morris, M.C. 2006. Docosahexaenoic acid and Alzheimer disease. Arch. Neurol. 63 : 1527 1528.
84. Morris, M.C. et al. 2003. Dietary fats and the risk of incident Alzheimer disease. Arch. Neurol. 60 : 194 200.
85. Morris, M.C. et al. 2003. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch. Neurol. 60 : 940 946.
86. Kotani, S. et al. 2006. Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction. Neurosci. Res. 56 : 159 164.
87. Scarmeas, N. et al. 2007. Mediterranean diet and Alzheimer disease mortality. Neurology 69 : 1084 1093.
88. Scarmeas, N. et al. 2006. Mediterranean diet and risk for Alzheimer's disease. Ann. Neurol. 59 : 912 921.
89. Scarmeas, N. et al. 2006. Mediterranean diet, Alzheimer disease, and vascular mediation. Arch. Neurol. 63 : 1709 1717.
90. Larson, E. et al. 2006. Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann. Intern. Med. 144 : 73 81.
91. Rolland, Y. et al. 2007. Exercise program for nursing home residents with Alzheimer's disease: a 1-year randomized, controlled trial. J. Am. Geriatr. Soc. 55 : 158 165.
92. Romeo, J. et al. 2008. Nutrition, stress and neuroimmunomodulation. Neuroimmunomodulation 15 (3 165 169.
93. Pukay-Martin, N.D. et al. 2003. The relationship between stressful life events and cognitive function in HIV-infected men. J. Neuropsychiatry Clin. Neurosci. 15 : 436 441.
94. Yaffe, K. et al. 2007. Metabolic syndrome and cognitive decline in elderly Latinos: findings from the Sacramento Area Latino Study of Aging study. J. Am. Geriatr. Soc. 55 : 758 762.
95. Gold, S.M. et al. 2005. Hypertension and hypothalamo-pituitary-adrenal axis hyperactivity affect frontal lobe integrity. J. Clin. Endocrinol. Metab. 90 : 3262 3267.
96. Bombois, S. et al. 2007. Prevalence of subcortical vascular lesions and association with executive function in mild cognitive impairment subtypes. Stroke 38 : 2595 2597.
97. Frisoni, G.B. et al. 2002. Mild cognitive impairment with subcortical vascular features: clinical characteristics and outcome. J. Neurol. 249 : 1423 1432.
98. Convit, A. 2005. Links between cognitive impairment in insulin resistance: an explanatory model. Neurobiol. Aging 26 : S31 35.
99. Starr, V.L. & A. Convit. 2007. Diabetes, sugar-coated but harmful to the brain. Curr. Opin. Pharmacol. 7 : 638 642.
100. Bjorgaas, M. et al. 1997. Cognitive function in type 1 diabetic children with and without episodes of severe hypoglycaemia. Acta Paediatr. 86 : 148 153.
101. Ryan, C.M. et al. 2006. Improving metabolic control leads to better working memory in adults with type 2 diabetes. Diabetes Care 29 : 345 351.
102. Elias, M.F. et al. 2005. Obesity, diabetes and cognitive deficit: The Framingham Heart Study. Neurobiol. Aging 26 : S11 16.
103. Sweat, V. et al. 2008. C-reactive protein is linked to lower cognitive performance in overweight and obese women. Inflammation 31 : 198 207.
104. Gunstad, J. et al. 2007. Elevated body mass index is associated with executive dysfunction in otherwise healthy adults. Compr. Psychiatry 48 : 57 61.
105. Jeong, S.K. et al. 2005. Interactive effect of obesity indexes on cognition. Dement Geriatr. Cogn. Disord. 19 : 91 96.
106. Cournot, M. et al. 2006. Relation between body mass index and cognitive function in healthy middle-aged men and women. Neurology 67 : 1208 1214.
107. Sakakura, K. et al. 2008. Association of body mass index with cognitive function in elderly hypertensive Japanese. Am. J. Hypertens. 21 : 627 632.
108. Maes, M. et al. 1997. Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatry Res. 66 : 1 11.
109. Maes, M. et al. 1992. Disturbances in acute phase plasma proteins during melancholia: additional evidence for the presence of an inflammatory process during that illness. Prog. Neuropsychopharmacol. Biol. Psychiatry 16 : 501 515.
110. Panagiotakos, D.B. et al. 2004. Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study. Eur. Heart J. 25 : 492 499.
111. Papageorgiou, C. et al. 2006. Association between plasma inflammatory markers and irrational beliefs; the ATTICA epidemiological study. Prog. Neuropsychopharmacol. Biol. Psychiatry 30 : 1496 1503.
112. Pitsavos, C. et al. 2006. Anxiety in relation to inflammation and coagulation markers, among healthy adults: the ATTICA study. Atherosclerosis 185 : 320 326.
113. Ford, D.E. & T.P. Erlinger. 2004. Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Arch. Intern. Med. 164 : 1010 1014.
114. Liukkonen, T. et al. 2006. The Association Between C-Reactive Protein Levels and Depression: Results from the Northern Finland 1966 Birth Cohort Study. Biol. Psychiatry 60 : 825 830.
115. Danner, M. et al. 2003. Association between depression and elevated C-reactive protein. Psychosom. Med. 65 : 347 356.
116. Das, U.N. 2007. Is depression a low-grade systemic inflammatory condition? Am. J. Clin. Nutr. 85 : 1665 1666 author reply 1666.
117. Kidd, P.M. 2007. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Altern. Med. Rev. 12 : 207 227.
118. Logan, A. 2003. Neurobehavioral aspects of omega-3 fatty acids: possible mechanisms and therapeutic value in major depression. Altern. Med. Rev. 8 : 410 425.
119. Otto, S.J., R.H. de Groot & G. Hornstra. 2003. Increased risk of postpartum depressive symptoms is associated with slower normalization after pregnancy of the functional docosahexaenoic acid status. Prostaglandins Leukot Essent Fatty Acids 69 : 237 243.
120. De Vriese, S.R., A.B. Christophe & M. Maes. 2003. Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: further evidence that lowered n-PUFAs are related to major depression. Life Sci. 73 : 3181 3187.
121. Iribarren, C. et al. 2004. Dietary intake of n-3, n-6 fatty acids and fish: relationship with hostility in young adults - the CARDIA study. Eur. J. Clin. Nutr. 58 : 24 31.
122. Green, P. et al. 2006. Red cell membrane omega-3 fatty acids are decreased in nondepressed patients with social anxiety disorder. Eur. Neuropsychopharmacol. 16 : 107 113.
123. Tanskanen, A. et al. 2001. Fish consumption and depressive symptoms in the general population in Finland. Psychiatr. Serv. 52 : 529 531.
124. Timonen, M. et al. 2004. Fish consumption and depression: the Northern Finland 1966 birth cohort study. J. Affect. Disord. 82 : 447 452.
125. Sanchez-Villegas, A. et al. 2007. Long chain omega-3 fatty acids intake, fish consumption and mental disorders in the SUN cohort study. Eur. J. Nutr. 46 : 337 346.
126. Hakkarainen, R. et al. 2004. Is low dietary intake of omega-3 fatty acids associated with depression? Am. J. Psychiatry 161 : 567 569.